This invention relates to pharmaceutical combinations suitable for treating the lower urinary tract symptoms associated with either overactive bladder or mild to moderate benign prostatic hyperplasia, which combinations contain an alpha-adrenoceptor antagonist and a 5-HT4 antagonist. The public identifier is accessible by a user associated with the set top box. There is also disclosed a vegetable oil based polyol having an acid number of 2. Plural trace wires of the first trace portion are arranged on first and second surfaces of the edge region.